Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 2,000 shares traded.
Resverlogix Price Performance
The company has a debt-to-equity ratio of -10.95, a current ratio of 0.13 and a quick ratio of 0.04. The company has a market cap of C$27.21 million, a PE ratio of -2.38 and a beta of 0.78. The company has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.08.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- Buy P&G Now, Before It Sets A New All-Time High
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- How to Invest in the FAANG Stocks
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
